GlassScriptPhysician profile
Paul Jerome Scherer
NPI 1881679181
$4,681.27
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,347 · 2020: $162 · 2021: $20.65 · 2022: $59.92 · 2023: $41.08 · 2024: $50.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,523.00 | 2019 | |
| Elite Orthopedics, LLC | $1,685.81 | 2019-2022 | |
| Depuy Synthes Sales INC. | $112.66 | 2019 | |
| Medical Device Business Services, INC. | $105.03 | 2020 | |
| Stryker Corporation | $69.44 | 2019-2020 | |
| Smith+Nephew, INC. | $47.16 | 2023-2024 | Pico 7, Renasys Go V2 Home, Pico 14 |
| Baudax Bio INC. | $36.46 | 2020-2021 | |
| Heraeus Medical, LLC. | $25.61 | 2024 | |
| Heron Therapeutics, INC. | $18.90 | 2023 | Zynrelef |
| Zimvie INC. | $16.59 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $14.92 | 2022 | |
| Pacira Therapeutics, INC. | $13.68 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Scherer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.